Top

Administration and Policy in Mental Health and Mental Health Services Research

Published in:

01-09-2017 | Original Article

Methods for Incorporating Patient Preferences for Treatments of Depression in Community Mental Health Settings

Authors: Paul Crits-Christoph, Robert Gallop, Caroline K. Diehl, Seohyun Yin, Mary Beth Connolly Gibbons

Published in: Administration and Policy in Mental Health and Mental Health Services Research | Issue 5/2017

Abstract

We developed three methods (rating, ranking, and discrete choice) for identifying patients’ preferred depression treatments based on their prioritization of specific treatment attributes (e.g., medication side effects, psychotherapy characteristics) at treatment intake. Community mental health patients with depressive symptoms participated in separate studies of predictive validity (N = 193) and short-term (1-week) stability (N = 40). Patients who received non-preferred initial treatments (based on the choice method) switched treatments significantly more often than those who received preferred initial treatments. Receiving a non-preferred treatment at any point (based on rating and choice methods) was a significant predictor of longer treatment duration. All three methods demonstrated good short-term stability.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders: DSM- IV (4th ed.). Washington: American Psychiatric Association.

APA Presidential Task Force on Evidence-Based Practice. (2006). Evidence-based practice in psychology. American Psychologist, 61(4), 271–285.CrossRef

Brodie, M. J., & Kwan, P. (2001). The star systems: Overview and use in determining antiepileptic drug choice. CNS Drugs, 15(1), 1–12. doi:10.2165/00023210-200115010-00001.CrossRefPubMed

Chilvers, C., Dewey, M., Fielding, K., Gretton, V., Miller, P., Palmer, B., & Harrison, G. (2001). Antidepressant drugs and generic counselling for treatment of major depression in primary care: Randomised trial with patient preference arms. BMJ, 322(7289), 772–775. doi:10.1136/bmj.322.7289.772.CrossRefPubMedPubMedCentral

Citrome, L., & Ketter, T. A. (2013). When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed. International Journal of Clinical Practice, 67, 407–411.CrossRefPubMed

Clever, S. L., Ford, D. E., Rubenstein, L. V., Rost, K. M., Meredith, L. S., Sherbourne, C. D., & Cooper, L. A. (2006). Primary care patients’ involvement in decision-making is associated with improvement in depression. Medical Care, 44(5), 398–405. doi:10.1097/01.mlr.0000208117.15531.da.CrossRefPubMed

Cohen, E. (2009). Applying best-worst scaling to wine marketing. International Journal of Wine Business Research, 21(1), 8–23. doi:10.1108/17511060910948008.CrossRef

Dolan, J. G. (1989). Medical decision making using the analytic hierarchy process: Choice of initial antimicrobial therapy for acute pyelonephritis. Medical Decision Making, 9(1), 51–56. doi:10.1177/0272989X8900900109.CrossRefPubMed

Dolan, J. G., & Bordley, D. R. (1994). Isoniazid prophylaxis: The importance of individual values. Medical Decision Making, 14(1), 1–8. doi:10.1177/0272989X9401400101.CrossRefPubMed

Dolan, J. G., & Frisina, S. (2002). Randomized controlled trial of a patient decision aid for colorectal cancer screening. Medical Decision Making, 22(2), 125–139. doi:10.1177/02729890222063017.CrossRefPubMed

Dwight-Johnson, M., Unutzer, J., Sherbourne, C., Tang, L., & Wells, K. B. (2001). Can quality improvement programs for depression in primary care address patient preferences for treatment? Medical Care, 39(9), 934–944. doi:10.1097/00005650-200109000-00004.CrossRefPubMed

Ferguson, J. M. (2001). SSRI antidepressant medications: Adverse effects and tolerability. Primary Care Companion Journal of Clinical Psychiatry, 3(1), 22–27.CrossRef

Finn, A., & Louviere, J. J. (1992). Determining the appropriate response to evidence of public concern: The case of food safety. Journal of Public Policy and Marketing, 11(2), 12–25.

Flynn, T. N., Louviere, J. J., Peters, T. J., & Coast, J. (2007). Best-worst scaling: What it can do for health care research and how to do it. Journal of Health Economics, 26(1), 171–189. doi:10.1016/j.jhealeco.2006.04.002.CrossRefPubMed

Flynn, T. N., Louviere, J. J., Peters, T. J., & Coast, J. (2008). Estimating preferences for a dermatology consultation using best-worst scaling: Comparison of various methods of analysis. BMC Medical Research Methodology, 8(1), 76. doi:10.1186/1471-2288-8-76.CrossRefPubMedPubMedCentral

Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K., Lux, L., Van Noord, M., & Lohr, K. N. (2011). Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Annals of Internal Medicine, 155, 772–785.CrossRefPubMed

Gitlin, M. (2003). Sexual dysfunction with psychotropic drugs. Expert Opinion on Pharmacotherapy, 4, 2259–2269.CrossRefPubMed

Goadsby, P. J., Dodick, D. W., Ferrari, M. D., McCrory, D. C., & Williams, P. (2004). TRIPSTAR: Prioritizing oral triptan treatment attributes in migraine management. Acta Neurologica Scandinavica, 110(3), 137–143. doi:10.1111/j.1600-0404.2004.00310.x.CrossRefPubMed

Guyatt, G., Cairns, J., Churchill, D., Cook, D., Haynes, B., Hirsh, J., & Tugwell, P. (1992). Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA, 268(17), 2420–2425. doi:10.1001/jama.1992.03490170092032.CrossRef

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23(1), 56–62. doi:10.1136/jnnp.23.1.56.CrossRefPubMed

Hummel, M. J. M., Volz, F., van Manen, J. G., Danner, M., Dintsios, C. M., Ijzerman, M. J., & Gerber, A. (2012). Using the analytic hierarchy process to elicit patient preferences: Prioritizing multiple outcome measures of antidepressant drug treatment. Patient, 5(4), 225–237. doi:10.2165/11635240-000000000-00000.CrossRefPubMed

Iacoviello, B. M., McCarthy, K. S., Barrett, M. S., Rynn, M., Gallop, R., & Barber, J. P. (2007). Treatment preferences affect the therapeutic alliance: Implications for randomized controlled trials. Journal of Consulting and Clinical Psychology, 75(1), 194–198. doi:10.1037/0022-006X.75.1.194.CrossRefPubMed

Institute of Medicine. (2001). Crossing the quality chasm: A new health system for the 21st century. Washington: National Academy Press.

Intercontinental Medical Systems. (2004). National disease and therapeutic index. Plymouth Meeting: IMS Health.

Keating, N. L., Guadagnoli, E., Landrum, M. B., Borbas, C., & Weeks, J. C. (2002). Treatment decision making in early-stage breast cancer: Should surgeons match patients’ desired level of involvement? Journal of Clinical Oncology, 20(6), 1473–1479. doi:10.1200/JCO.20.6.1473.PubMedCrossRef

Kocher, M. S., Bishop, J., Marshall, R., Briggs, K. K., & Hawkins, R. J. (2002). Operative versus nonoperative management of acute achilles tendon rupture: Expected-value decision analysis. American Journal of Sports Medicine, 30(6), 783–790. doi:10.1177/03635465020300060501.CrossRefPubMed

Lin, P., Campbell, D. G., Chaney, E. F., Liu, C. F., Heagerty, P., Felker, B. L., & Hedrick, S. C. (2005). The influence of patient preference on depression treatment in primary care. Annals of Behavioral Medicine, 30(2), 164–173. doi:10.1207/s15324796abm3002_9.CrossRefPubMed

Louviere, J. J., Flynn, T. N., & Marley, A. A. J. (2015). Best-worst scaling: Theory, methods and applications. Cambridge: Cambridge University Press.CrossRef

Marley, A. A. J., Flynn, T. N., & Louviere, J. J. (2008). Probabilistic models of set-dependent and attribute-level best-worst choice. Journal of Mathematical Psychology, 52(5), 281–296. doi:10.1016/j.jmp.2008.02.002.CrossRef

Marley, A. A. J., & Louviere, J. J. (2005). Some probabilistic models of best, worst, and best–worst choices. Journal of Mathematical Psychology, 49(6), 464–480. doi:10.1016/j.jmp.2005.05.003.CrossRef

Montejo, A. L., Llorca, G., Izquierdo, J. A., Rico-Villademoros, F., & and the Spanish Working Group for the Study of Psychotropic Related Sexual Dysfunction. (2001). Incidence of sexual dysfunction associated with antidepressant agents. A prospective multicenter study of 1022 outpatients. Journal of Clinical Psychiatry, 62(supplement 3), 10–21.PubMed

Pagel, J. F., & Parnes, B. L. (2001). Medications for the treatment of sleep disorders. Primary Care Companion Journal of Clinical Psychiatry, 3, 125–188.CrossRef

Riche, N., Duvinage, M., Mancas, M., Gosselin, B., & Dutoit, T. (2013). A study of parameters affecting visual saliency assessment. Proceedings of the 6 ^th International Symposium on Attention in Cognitive Systems. (ISACS’13),). Beijing, China, August 3–5. http://arxiv.org/abs/1307.5691v1.

Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., & Keller, M. B. (2003). The 16-item Quick Inventory Of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583. doi:10.1016/S0006-3223(02)01866-8.CrossRefPubMed

Sackett, D. L. (2000). Evidence-based medicine. New York: Wiley.

Schumacher, G. E. (1991). Multiattribute evaluation in formulary decision making as applied to calcium-channel blockers. American Journal of Hospital Pharmacy, 48(2), 301–308.PubMed

Schweitzer, I., Mcguire, K., & Chee, N. (2009). Sexual side-effects of contemporary antidepressants: Review. Australian and New Zealand Journal of Psychiatry, 43, 795–808.CrossRefPubMed

Serritti, A., & Chiesa, A. (2011). A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. International Clinical Psychopharmacology, 26, 130–140.CrossRef

van Schaik, D. J., Klijn, A. F., van Hout, H. P., van Marwijk, H. W., Beekman, A. T., de Haan, M., & van Dyck, R. (2004). Patients’ preferences in the treatment of depressive disorder in primary care. General Hospital Psychiatry, 26(3), 184–189. doi:10.1016/j.genhosppsych.2003.12.001.CrossRefPubMed

Watanabe, N., Omori, I. O., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., et al. (2010). Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: Systematic review and meta-analysis. CNS Drugs, 24(1), 35–53.CrossRefPubMed

Wittink, M. N., Cary, M., TenHave, T., Baron, J., & Gallo, J. J. (2010). Towards patient-centered care for depression. The Patient: Patient-Centered Outcomes Research, 3(3), 145–157. doi:10.2165/11530660-000000000-00000.CrossRef

Wittink, M. N., Morales, K. H., Cary, M., Gallo, J. J., & Bartels, S. J. (2013). Towards personalizing treatment for depression: developing treatment values markers. The Patient: Patient-Centered Outcomes Research, 6(1), 35–43. doi:10.1007/s40271-013-0003-6.CrossRef

Yoon, K., & Hwang, C.-L. (1995). Multiple attribute decision making. Thousand Oaks: SAGE Publications Inc.CrossRef

Zimmermann, T. M., Clouth, J., Elosge, M., Heurich, M., Schneider, E., Wilhelm, S., & Wolfrath, A. (2013). Patient preferences for outcomes of depression treatment in Germany: A choice-based conjoint analysis study. Journal of Affective Disorder, 148(2–3), 210–219. doi:10.1016/j.jad.2012.11.062.CrossRef

Title: Methods for Incorporating Patient Preferences for Treatments of Depression in Community Mental Health Settings
Authors: Paul Crits-Christoph
Robert Gallop
Caroline K. Diehl
Seohyun Yin
Mary Beth Connolly Gibbons
Publication date: 01-09-2017
Publisher: Springer US
Published in: Administration and Policy in Mental Health and Mental Health Services Research / Issue 5/2017
Print ISSN: 0894-587X
Electronic ISSN: 1573-3289
DOI: https://doi.org/10.1007/s10488-016-0746-1

At a glance: The STEP trials

Springer Medicine

Methods for Incorporating Patient Preferences for Treatments of Depression in Community Mental Health Settings

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2017

Harnessing the Therapist Effect in Patient-Centered Mental Health Care Decision Making

Therapist-Specific Factors and Psychotherapy Outcomes of Adult and Youth Clients Seen in a Psychology Training Clinic

Therapist Reflective Functioning, Therapist Attachment Style and Therapist Effectiveness

Benchmarking Family Therapy for Adolescent Behavior Problems in Usual Care: Fidelity, Outcomes, and Therapist Performance Differences

The Therapist’s Role in Effective Marriage and Family Therapy Practice: The Case for Evidence Based Therapists

The Relationship Between Therapist Effects and Therapy Delivery Factors: Therapy Modality, Dosage, and Non-completion